Bechtel joined Carlyle in 2005 as the head of the Global Healthcare team and currently is focused on corporate buyout opportunities within the private equity market. Prior to her role at Carlyle, for 28 years, she held a variety of leadership roles within Morgan Stanley & Co., including as Managing Director of the Private Equity Group. During her esteemed career with Morgan Stanley, Bechtel was also co-head of the Financial Sponsors Group and head of the Corporate Restructuring Group, with a strong focus on healthcare investments as well as mergers and acquisitions. She was also a member of the firm's Investment Banking Operating Committee.
In addition to her role as a new MassMutual Director, Bechtel serves on the Boards of Ortho Clinical Diagnostics, HCR-ManorCare, and Pharmaceutical Product Development, LLC. She is also a former Board member of Healthscope Ltd., Grupo Qualicorp, Multiplan, Inc., and LifeCare.
Mergers & Acquisitions magazine in 2015 named her one of the Most Influential Women in mid-market M&A.
Bechtel received her bachelor's degree in mathematics from the University of Texas at Austin and earned her MBA from the Harvard Graduate School of Business.
MassMutual is a leading mutual life insurance company that is run for the benefit of its members and participating policyowners. MassMutual offers a wide range of financial products and services, including life insurance, disability income insurance, long term care insurance, annuities, retirement plans and other employee benefits. For more information, visit www.massmutual.com.
MassMutual Financial Group is a marketing name for Massachusetts Mutual Life Insurance Company (MassMutual) and its affiliated companies and sales representatives.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/massmutual-elects-karen-bechtel-to-its-board-of-directors-300323802.html